COMMUNIQUÉS West-GlobeNewswire

-
T2 Biosystems Awarded Breakthrough Technology Contract with Premier Inc.
10/09/2019 -
Lexicon Pharmaceuticals to Present Sotagliflozin Clinical Data at the European Association for the Study of Diabetes 55th Annual Meeting
10/09/2019 -
Lexicon Pharmaceuticals Announces Termination of Alliance and Settlement With Sanofi
10/09/2019 -
Civil rights movement intensifies as hate crimes increase in LGBTQ communities in Africa
10/09/2019 -
Need a Clean Slate? How to Care for Your Skin After Tattoo Removal; American Academy of Dermatology
10/09/2019 -
Emerald Health Therapeutics Announces Closing of $25 million Convertible Debenture Unit Financing
10/09/2019 -
The Delta Companies’ Ty Chambers Takes On New Role as President of Client Services
10/09/2019 -
Inventiva announces the positive recommendation of the 4th and last DSMB of the Phase IIb clinical study with lanifibranor in NASH
10/09/2019 -
Inventiva annonce l’avis positif du 4ème et dernier DSMB de l’étude clinique de Phase IIb avec lanifibranor dans la NASH
10/09/2019 -
Windsor Strategy Partners Appoints Paul Fallisi as President
10/09/2019 -
Tauriga Sciences, Inc. Obtains Approval of its Stockholders to Increase its Authorized Common Stock at Special Shareholder Meeting
10/09/2019 -
Vaxil Announces Private Placement
10/09/2019 -
HIMSS Shares Early Achievements from “Data: Elemental to Health” Campaign
10/09/2019 -
Pressure BioSciences’ PCT Platform Identified as Pivotal for Cancer Biomarker Discovery and for Potential Clinical Diagnostics
10/09/2019 -
AssistRx Appoints Jan Nielsen as Division President of Patient Solutions Business
10/09/2019 -
PHASTAR Names Dr. Jennifer Bradford to Head Data Science Group
10/09/2019 -
Innovation Pharmaceuticals Plans for Clinical Trial of Oral Brilacidin for Ulcerative Colitis Program in 4th Quarter 2019
10/09/2019 -
Ultragenyx and Kyowa Kirin Announce Intent to Submit Supplemental Biologics License Application to U.S. FDA for Crysvita® (burosumab) in Tumor-Induced Osteomalacia (TIO)
10/09/2019 -
Keith Cook Named President of Comprehensive Pharmacy Services Ambulatory & Specialty Pharmacy Division
10/09/2019
Pages